Sign In

Новини и Събития

Assoc. Prof. Dr. Plamen Panayotov Presented the Possibilities of Cardiac Surgery for Treating End-stage Heart Failure

Assoc. Prof. Dr. Plamen Panayotov, PhD from the Department of Surgical Diseases delivered an academic lecture on "Possibilities of Modern Cardiac Surgery for Treating End-stage Heart Failure", at 2.30 pm, on 7th October, in "Prof. Vl. Ivanov" auditorium at St. Marina University Hospital in Varna. The lecture was open to everyone interested in the topic - students, lecturers, intern doctors, specializing doctors, general practitioners, medical specialists, interested citizens and patients.

In Assoc. Prof. Plamen Panayotov's academic lecture were presented the possibilities of modern cardiac surgery for implementation of heart supporting systems - Ventricular Assisting Devices (VAD). The introduction of these methods in the University cardiac surgery will give the patients from Northeastern Bulgaria the chance to gain access to this extremely highly specialized medical care - implantation of a suitable VAD system and appropriate supportive treatment and monitoring. At the initiative and under the direction of the Rector of Medical University - Varna, Prof. Dr. Krasimir Ivanov, the preparation of a project for treating end-stage heart failure is being launched at the Clinic of Cardiac Surgery of St. Marina University Hospital, which will be implemented in cooperation with the leading in this field Clinics of Cardiac Surgery in Augsburg and Berlin.

Cardiac surgery has more than 60 years of history and in Bulgaria modern cardiac surgery has been performed  for 25 years. Along with the achievements that have been introduced in everyday practice - valve-sparing operations, arterial revascularization, aortic surgery and others, it is time to introduce other advanced technologies that will enhance the quality of patients' life. Such methods are the surgical methods for treatment of end-stage heart failure. Even in the most developed in terms of cardiac transplantation countries, only 20% of the patients survive to a successful transplant. This requires the application of more alternative solutions, such as implantation of heart assist systems, by means of which the patients can survive five and even more years.